April 26, 2018 / 3:42 PM / 7 months ago

BRIEF-CEO Says Bristol-Myers Still A Growth Company

April 26 (Reuters) - Bristol-Myers Squibb Co:

* BRISTOL-MYERS SQUIBB SEES CONTINUED GROWTH IN ANTICOAGULANT MARKET SHARE FOR ELIQUIS

* BRISTOL-MYERS CEO SAYS CONTINUES TO SEE BMS AS A GROWTH COMPANY AND OPDIVO AS A GROWTH FRANCHISE Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below